Nuveen’s Abbott ABT Stock Holding History

Nuveen’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43,800	Closed	-$3K	–	3267
2020 Q1	$3K	Buy	+43,800	New	+$3.65M	﹤0.01%	3169

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen's ABT Position: Q1 2026 in Review

Nuveen reduced its Abbott (ABT) stake by 5.1% in Q1 2026, selling an estimated $68.1M and leaving 11,191,853 shares worth $1.15B. The position accounts for 0.31% of the portfolio, ranked #62.

Nuveen first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.66B in Q2 2025. 3,097 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Nuveen held 11,191,853 shares of Abbott worth $1.15B as of Q1 2026.
Nuveen sold 602,952 Abbott shares in Q1 2026, an estimated $68.1M.
Abbott made up 0.31% of Nuveen's portfolio in Q1 2026, its #62 holding.
Nuveen first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
Nuveen's Abbott position peaked at $1.66B in Q2 2025.
3,097 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.